Pfizer Requests FDA Approval for COVID-19 Vaccine for Children

Pfizer and its partner BioNTech have asked the Food and Drug Administration for Emergency Use Authorization of their coronavirus vaccine for children ages 5 to 12. In anticipation of the submission, the FDA scheduled a meeting on the application for October 26. Click here for more.